<DOC>
	<DOCNO>NCT01580254</DOCNO>
	<brief_summary>This study examine efficacy tolerability 3 different Latanoprost 0.005 % eyedrops preparation , commercially available Italy , subject affect primary open angle glaucoma .</brief_summary>
	<brief_title>Efficacy Safety Three Different Latanoprost 0,005 % Eyedrops Subjects Affected Primary Open Angle Glaucoma</brief_title>
	<detailed_description>Prospective , randomize , single blind study duration 3 month , involve subject affect POAG OH therapy different Latanoprost drug ( Galaxia , Iopize Latanoprost Rathiopharm ) . A total 120 patient affected POAG OH newly diagnose already topical therapy . recruit . After recruitment visit assest eligibility subject , `` run-in '' therapy compose timolol 0,5 % 2 drop per day prescribe 4 week . Then baseline visit perform evaluate IOP value adverse effect subject . All subject elegible therapy single dose Latanoprost randomize 3 arm . After 4 week therapy second visit make assest IOP change safety . Therapy continue another 4 week , , final visit make .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Age range 18 80 Untreated IOP range 21 30 mmHg IOP already treat single drug ( monotherapy ) range 10 28 mmHg History adverse event controindication drug administred sperimentation , i. e. Latanoprost Timolol . Narrow close iridocorneal angle . History acute angleclosure glaucoma . Previous laser trabeculoplasty within 3 month screen . Severe visual field defect within 10Â° fixation least one eye ( least 2 point p &lt; 0,5 pattern deviation map obtain reliable 242 Sita Standard SAP ) . History refractive surgery keratoplasty procedure , corneal opacity disease make suitable applanation tonometry . Use contact lens . BCVA le 20/200 . Ocular inflammation/infection occur within three month screen . History bradicardia , systemic hypotension , bundle branch atrioventricular block Asthma Women childbearing potential use adequate contraceptive method pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Latanoprost</keyword>
	<keyword>IOP</keyword>
</DOC>